vorasidenib
servier
['dinner', 'indigo', 'melanoma', 'melsm']
day 3 #asco2023 highlight s - #indigo trial for glioma!! great talk on novel immunotherapy agents by #melsm (melanoma) excellent osu scarlet and grey dinner to end the day looking forward to day 4 before heading out ! 
Hematology-Oncology Fellow @OSUCCC_James. Internal Medicine Resident @MSM_GME, Assoc editor @themednet. # Healthcare Disparities in Cancer Care. Melanoma/GU.